PharmaCyte Biotech, Inc. (PMCB) › Net IncomePharmaCyte Biotech, Inc. (PMCB) — Net IncomeAnnual figures by fiscal year, from SEC filings.2011: -$1.40M2012: -$1.90M2013: -$1.60M2014: -$27.25M2015: -$9.93M2016: -$6.06M2017: -$4.44M2018: -$6.83M2019: -$4.07M2020: -$3.83M2021: -$3.55M2022: -$4.24M2023: -$4.32M2024: $333.8K2025: $30.66M$30.66M2011Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$30.66M+9085.0%2024$333.8K+107.7%2023-$4.32M-1.8%2022-$4.24M-19.4%2021-$3.55M+7.2%2020-$3.83M+5.9%2019-$4.07M+40.4%2018-$6.83M-53.7%2017-$4.44M+26.7%2016-$6.06M+38.9%2015-$9.93M+63.6%2014-$27.25M-1605.4%2013-$1.60M+15.9%2012-$1.90M-35.9%2011-$1.40M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share